Approval · Notice of Compliance 38233 · 2026
OLMETEC PLUS: Notice of Compliance 38233
Issued September 3, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 38233
- Date
- September 3, 2026
- Company
- Organon Canada Inc.Kirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph as per advisement letter. Product Monograph reformatted to the Master Template
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OLMETEC PLUS | Not yet assigned | — |
Medicinal ingredients
- HYDROCHLOROTHIAZIDE 25 MG per TAB
- OLMESARTAN MEDOXOMIL 40 MG per TAB
- HYDROCHLOROTHIAZIDE 12.5 MG per TAB
- OLMESARTAN MEDOXOMIL 20 MG per TAB